Cargando…
Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
Radioimmunotherapy (i.e., the use of radiolabeled tumor targeting antibodies) is an emerging approach for the diagnosis, therapy, and monitoring of solid tumors. Often using paired agents, each targeting the same tumor molecule, but labelled with an imaging or therapeutic isotope, radioimmunotherapy...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504276/ https://www.ncbi.nlm.nih.gov/pubmed/34646364 http://dx.doi.org/10.1177/17588359211022918 |